SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
05-Mar-24 5:00 PM View: | Kinnate Biopharma Inc. (KNTE) | 01-Mar-24 | Payment of Exercise | 558 | $2.59 | $1,445.22 | (< 1%) 68.15K to 67.59K | |
05-Dec-23 5:00 PM View: | Kinnate Biopharma Inc. (KNTE) | 01-Dec-23 | Payment of Exercise | 541 | $2.25 | $1,217.25 | (< 1%) 68.69K to 68.15K | |
06-Sep-23 5:00 PM View: | Kinnate Biopharma Inc. (KNTE) | 01-Sep-23 | Payment of Exercise | 541 | $2.35 | $1,271.35 | (< 1%) 69.23K to 68.69K | |
05-Jun-23 5:01 PM View: | Kinnate Biopharma Inc. (KNTE) | 01-Jun-23 | Payment of Exercise | 541 | $4.30 | $2,326.30 | (< 1%) 69.77K to 69.23K | |
03-Mar-23 5:58 PM View: | Kinnate Biopharma Inc. (KNTE) | 01-Mar-23 | Payment of Exercise | 638 | $5.21 | $3,323.98 | (< 1%) 67.93K to 67.3K | |
02-Dec-22 8:00 PM View: | Kinnate Biopharma Inc. (KNTE) | 01-Dec-22 | Payment of Exercise | 541 | $7.75 | $4,192.75 | (< 1%) 68.47K to 67.93K | |
02-Sep-22 5:00 PM View: | Kinnate Biopharma Inc. (KNTE) | 01-Sep-22 | Grant | 25,000 | -- | -- | 58% 43.47K to 68.47K | |
15-Mar-22 5:01 PM View: | Kinnate Biopharma Inc. (KNTE) | 14-Mar-22 | Purchase | 25,000 | $8.37 | $209,250.00 | 144% 17.33K to 42.33K | |
15-Mar-22 5:01 PM View: | Kinnate Biopharma Inc. (KNTE) | 11-Mar-22 | Private Purchase | 15,000 | $8.64 | $129,600.00 | 643% 2.33K to 17.33K |